Several investigations have linked elevated B7-H3 expression with poorer prognostic outcomes in RCC, associating it with diminished overall survival (OS), disease-specific survival (DSS), and shorter disease-free survival periods [69,164]. This evidence concerns the gene CD276 and renal cell carcinoma.